Initial (60-day) Federal Register Notice

21123

Federal Register / Vol. 87, No. 69 / Monday, April 11, 2022 / Notices
213, WC Docket No. 20–89 (FCC 20–44),
establishing two programs designed to
assist health care providers in providing
connected care services to consumers—
the COVID–19 Telehealth Program and
the Connected Care Pilot Program
(collectively, Programs). June 2021, the
Commission adopted a Second Report
and Order, WC Docket No. 18–213 (FCC
21–74), that provided guidance on
eligible services, competitive bidding,
invoicing, and data reporting for Pilot
Program participants. The information
collected herein is necessary to meet the
specific requirements for information
that must be submitted as part of the
annual and final reports to the
Commission as outlined in the Second
Connected Care Report and Order, and
for the Commission to receive and
evaluate data for the selected projects
and ensure compliance with the
Commission’s rules and procedures
applicable to the Connected Care Pilot
Program. This submission does not
make any changes to the previously
approved information collections for the
COVID–19 Telehealth Program and
some of the previously approved
requirements for the Pilot Program.
Federal Communications Commission.
Marlene Dortch,
Secretary, Office of the Secretary.
[FR Doc. 2022–07631 Filed 4–8–22; 8:45 am]
BILLING CODE 6712–01–P

FEDERAL DEPOSIT INSURANCE
CORPORATION
[OMB No. 3064–0207]

Agency Information Collection
Activities: Proposed Collection
Renewal; Comment Request
Federal Deposit Insurance
Corporation (FDIC).
ACTION: Notice and request for comment.
AGENCY:

The FDIC, as part of its
obligations under the Paperwork
Reduction Act of 1995 (PRA), invites the
general public and other Federal
agencies to take this opportunity to
comment on the renewal of the existing
information collection described below
(OMB Control No. 3064–0207).
DATES: Comments must be submitted on
or before June 10, 2022.
ADDRESSES: Interested parties are
invited to submit written comments to
the FDIC by any of the following
methods:
• Agency Website: https://
www.fdic.gov/resources/regulations/
federal-register-publications/.
• Email: comments@fdic.gov. Include
the name and number of the collection
in the subject line of the message.
• Mail: Manny Cabeza (202–898–
3767), Regulatory Counsel, MB–3128,
Federal Deposit Insurance Corporation,
SUMMARY:

550 17th Street NW, Washington, DC
20429.
• Hand Delivery: Comments may be
hand-delivered to the guard station at
the rear of the 17th Street NW building
(located on F Street NW), on business
days between 7:00 a.m. and 5:00 p.m.
All comments should refer to the
relevant OMB control number. A copy
of the comments may also be submitted
to the OMB desk officer for the FDIC:
Office of Information and Regulatory
Affairs, Office of Management and
Budget, New Executive Office Building,
Washington, DC 20503.
FOR FURTHER INFORMATION CONTACT:

Manny Cabeza, Regulatory Counsel,
202–898–3767, mcabeza@fdic.gov, MB–
3128, Federal Deposit Insurance
Corporation, 550 17th Street NW,
Washington, DC 20429.
SUPPLEMENTARY INFORMATION:

Proposal to renew the following
currently approved collection of
information:
1. Title: Loans in Areas Having
Special Flood Hazards.
OMB Number: 3064–0207.
Form Number: None.
Affected Public: Private Sector.
Burden Estimate:

BURDEN CALCULATION
[OMB No. 3064–0207]
Estimated
annual
number of
respondents

lotter on DSK11XQN23PROD with NOTICES1

Description

Recordkeeping:
Private flood Insurance (Required to obtain benefits) ..............................
Standard flood hazard determination form (Mandatory) ..........................
Retention of notice of special flood hazards and availability of Federal
disaster relief assistance (Mandatory) ..................................................
Disclosure:
Notice of requirement to escrow flood insurance payments and fees
(Mandatory) ...........................................................................................
Change in status (Mandatory) ..................................................................
Notice of option to escrow flood insurance payments and fees (Mandatory) .......................................................................................................
Notice to borrower to purchase flood insurance (Mandatory) ..................
Notification to terminate flood insurance purchased on behalf of a borrower (Mandatory) .................................................................................
Notice of special flood hazards and availability of Federal disaster relief
assistance (Mandatory) .........................................................................
Notice to Administrator of FEMA of servicer’s identity (Mandatory) ........
Notice to Administrator of FEMA of a change in loan servicer (Mandatory) .......................................................................................................

Total Estimated Burden Hours:
$117,612.48.
General Description of Collection:
Each supervised lending institution is

VerDate Sep<11>2014

17:39 Apr 08, 2022

Jkt 256001

Frm 00041

Fmt 4703

Sfmt 4703

Estimated
hours per
response

Total hours

3,106
3,106

1
313

0.500
0.042

1,553.00
40,831.48

3,106

36

0.250

27,954.00

470
30

82
2

0.083
40

3,198.82
2,400.00

30
3,106

22
10

0.083
0.083

54.78
2,577.98

3,106

1

0.250

776.50

3,106
3,106

36
18

0.250
0.083

27,954.00
4,640.36

3,106

22

0.083

5,671.56

required to provide a notice of special
flood hazards to a borrower acquiring a
loan secured by a building on real
property located in an area identified by

PO 00000

Estimated
annual
number of
responses per
respondent

FEMA as subject to special flood
hazards, and various other notices to
borrowers, servicers and FEMA. The
Riegle Community Development Act

E:\FR\FM\11APN1.SGM

11APN1

21124

Federal Register / Vol. 87, No. 69 / Monday, April 11, 2022 / Notices

requires that each institution also
provide a copy of the notice to the
servicer of the loan (if different from the
originating lender). Section 100239 of
the Biggert-Waters Flood Insurance
Reform Act of 2012 requires each
federal banking agency (including the
FDIC), and the Farm Credit
Administration, to adopt implementing
regulations to direct regulated lending
institutions to accept ‘‘private flood
insurance,’’ as defined by the BiggertWaters Act. A lending institution would
be required to implement policies and
procedures to comply with the BiggertWaters Act provision and verify in
writing that a private insurance policy
satisfies the criteria included in the
definition or document findings that
separate required criteria have been met
when accepting a private flood
insurance policy in satisfaction of the
mandatory flood insurance purchase
requirement of the Flood Disaster
Protection Act. The institution must
also maintain records to permit
examination staff to ascertain how the
institution has met the requirements of
the regulation.
The FDIC has reviewed its previous
submission related to the PRA and has
updated its methodology to align with
the Office of the Comptroller of the
Currency’s corresponding information
collection (1557–0326). The decrease in
the estimated annual burden of 409,935
hours is the result of this change in
methodology.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Request for Comment

Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the

lotter on DSK11XQN23PROD with NOTICES1

Comments are invited on: (a) Whether
the collection of information is
necessary for the proper performance of
the FDIC’s functions, including whether
the information has practical utility; (b)
the accuracy of the estimates of the
burden of the information collection,
including the validity of the
methodology and assumptions used; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. All comments will become
a matter of public record.
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on April 5, 2022.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2022–07639 Filed 4–8–22; 8:45 am]
BILLING CODE 6714–01–P

VerDate Sep<11>2014

17:39 Apr 08, 2022

Jkt 256001

Food and Drug Administration
[Docket No. FDA–2022–D–0552]

Safety and Performance Based
Pathway Device-Specific Guidances;
Guidance for Industry and Food and
Drug Administration Staff; Availability
AGENCY:

Food and Drug Administration,

HHS.
ACTION:

Notice of availability.

The Food and Drug
Administration (FDA or Agency) is
announcing the availability of two final
device-specific guidance documents for
the Safety and Performance Based
Pathway—specifically, ‘‘Surgical
Sutures—Performance Criteria for Safety
and Performance Based Pathway’’ and
‘‘Orthopedic Fracture Fixation Plates—
Performance Criteria for Safety and
Performance Based Pathway.’’ The
device-specific guidances identified in
this notice were developed in
accordance with the finalized guidance
entitled ‘‘Safety and Performance Based
Pathway.’’
DATES: The announcement of the
guidances is published in the Federal
Register on April 11, 2022.
ADDRESSES: You may submit either
electronic or written comments on
Agency guidances at any time as
follows:
SUMMARY:

Electronic Submissions

PO 00000

Frm 00042

Fmt 4703

Sfmt 4703

manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2022–D–0552 for ‘‘Surgical Sutures—
Performance Criteria for Safety and
Performance Based Pathway’’ or
‘‘Orthopedic Fracture Fixation Plates—
Performance Criteria for Safety and
Performance Based Pathway.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.

E:\FR\FM\11APN1.SGM

11APN1